What is the difference between CJC-1295 / Ipamorelin and Tesamorelin?

The main difference is mechanism and research stage. CJC-1295 / Ipamorelin targets GHRH analog + ghrelin secretagogue (preclinical / research) and is studied for endogenous GH-pulse research; Tesamorelin targets GHRH analog (approved formulations exist) and is studied for visceral/hepatic fat research. Both are research-use-only compounds, not for human or animal use.

Are CJC-1295 / Ipamorelin and Tesamorelin approved for human use?

No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — CJC-1295 / Ipamorelin: preclinical / research; Tesamorelin: approved formulations exist — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.

How is purity verified for CJC-1295 / Ipamorelin and Tesamorelin?

Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.

Research Comparison

CJC-1295 / Ipamorelin vs Tesamorelin

CJC-1295 / Ipamorelin and Tesamorelin are often compared because both sit in growth-hormone axis research. CJC-1295 / Ipamorelin acts on GHRH analog + ghrelin secretagogue and is studied for endogenous GH-pulse research, while Tesamorelin acts on GHRH analog and is studied for visceral/hepatic fat research. Both are supplied as lyophilized powder for in-vitro laboratory research only — this page compares mechanism and research status, not dosing or human use.

CJC-1295 / Ipamorelin

Growth-hormone axis

Tesamorelin

Growth-hormone axis

Frequently asked

What is the difference between CJC-1295 / Ipamorelin and Tesamorelin?: The main difference is mechanism and research stage. CJC-1295 / Ipamorelin targets GHRH analog + ghrelin secretagogue (preclinical / research) and is studied for endogenous GH-pulse research; Tesamorelin targets GHRH analog (approved formulations exist) and is studied for visceral/hepatic fat research. Both are research-use-only compounds, not for human or animal use.
Are CJC-1295 / Ipamorelin and Tesamorelin approved for human use?: No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — CJC-1295 / Ipamorelin: preclinical / research; Tesamorelin: approved formulations exist — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.
How is purity verified for CJC-1295 / Ipamorelin and Tesamorelin?: Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.

Related comparisons

CJC-1295 / Ipamorelin vs Sermorelin MOTS-C vs Tesamorelin Sermorelin vs Tesamorelin

Build a multi-compound set in the Stack Builder or run the reconstitution calculator.

Research references

Primary literature for CJC-1295 / Ipamorelin and Tesamorelin. Provided for scientific context only — not medical or dosing guidance.

Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID 16352683 →
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID 9849822 →
Falutz J, et al. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation. J Acquir Immune Defic Syndr. 2010. PMID 20101189 →
Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation. JAMA. 2014. PMID 25038357 →

Research use only. This comparison covers mechanism, target, and research status. It is not medical, therapeutic, or dosing advice. Compounds sold by Renova Wellness™ are for in-vitro laboratory research and are not for human or animal consumption.